Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
Is a |
Dexbrompheniramine maleate |
false |
Inferred relationship |
Some |
|
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexbrompheniramine maleate (substance) |
false |
Inferred relationship |
Some |
|
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
Is a |
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride |
false |
Inferred relationship |
Some |
|
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Some |
|
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Brompheniramine (substance) |
false |
Inferred relationship |
Some |
|
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pseudoephedrine hydrochloride |
false |
Inferred relationship |
Some |
|
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrocodone bitartrate |
false |
Inferred relationship |
Some |
|
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Brompheniramine maleate |
false |
Inferred relationship |
Some |
|
|